These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 19737438)

  • 1. Quinidine therapy in children affected by Brugada syndrome: are we far from a safe alternative?
    Baruteau AE; Mabo P; Probst V
    Cardiol Young; 2009 Dec; 19(6):652-4. PubMed ID: 19737438
    [No Abstract]   [Full Text] [Related]  

  • 2. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry.
    Viskin S; Wilde AA; Tan HL; Antzelevitch C; Shimizu W; Belhassen B
    Heart Rhythm; 2009 Mar; 6(3):401-4. PubMed ID: 19251219
    [No Abstract]   [Full Text] [Related]  

  • 3. Brugada syndrome in children: don't ask, don't tell?
    Viskin S
    Circulation; 2007 Apr; 115(15):1970-2. PubMed ID: 17438161
    [No Abstract]   [Full Text] [Related]  

  • 4. Successful acute and long-term management of electrical storm in Brugada syndrome using orciprenaline and quinine/quinidine.
    Schweizer PA; Becker R; Katus HA; Thomas D
    Clin Res Cardiol; 2010 Jul; 99(7):467-70. PubMed ID: 20221832
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrical storm in Brugada syndrome successfully treated with orciprenaline; effect of low-dose quinidine on the electrocardiogram.
    Kyriazis K; Bahlmann E; van der Schalk H; Kuck KH
    Europace; 2009 May; 11(5):665-6. PubMed ID: 19346290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On Brugada syndrome.
    Zeller L; Shalev A
    Isr Med Assoc J; 2008 Oct; 10(10):743; author reply 743. PubMed ID: 19009962
    [No Abstract]   [Full Text] [Related]  

  • 7. Quinidine: a valuable medication joins the list of 'endangered species'.
    Viskin S; Antzelevitch C; Márquez MF; Belhassen B
    Europace; 2007 Dec; 9(12):1105-6. PubMed ID: 17761793
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of quinidine in high-risk patients with Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Circulation; 2004 Sep; 110(13):1731-7. PubMed ID: 15381640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is quinidine the ideal drug for brugada syndrome?
    Belhassen B
    Heart Rhythm; 2012 Dec; 9(12):2001-2. PubMed ID: 23063867
    [No Abstract]   [Full Text] [Related]  

  • 10. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome.
    Belhassen B; Glick A; Viskin S
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):294-301. PubMed ID: 19272057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anesthetic management of a patient with Brugada syndrome.
    Canbay O; Erden IA; Celebi N; Aycan IO; Karagoz AH; Aypar U
    Paediatr Anaesth; 2007 Dec; 17(12):1225-7. PubMed ID: 17986051
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term follow-up of primary prophylactic implantable cardioverter-defibrillator therapy in Brugada syndrome.
    Bonny A; Tonet J; Fontaine G; Frank R
    Eur Heart J; 2007 Nov; 28(22):2819-20; author reply 2820-1. PubMed ID: 17951573
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of low-dose quinidine on ventricular tachyarrhythmias in patients with Brugada syndrome: low-dose quinidine therapy as an adjunctive treatment.
    Mizusawa Y; Sakurada H; Nishizaki M; Hiraoka M
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):359-64. PubMed ID: 16633076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elimination of late potentials by quinidine in a patient with Brugada syndrome.
    Watanabe H; Chinushi M; Osaki A; Okamura K; Izumi D; Komura S; Hosaka Y; Tanabe Y; Furushima H; Washizuka T; Aizawa Y
    J Electrocardiol; 2006 Jan; 39(1):63-6. PubMed ID: 16387054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One small step.
    Link M; Kowey P
    Pacing Clin Electrophysiol; 2009 Mar; 32(3):291-3. PubMed ID: 19272056
    [No Abstract]   [Full Text] [Related]  

  • 16. [Topical optical beta-adrenergic antagonists and quinidine--a risky combination].
    Pianka P; Lazar M; Geyer O
    Harefuah; 1998 Mar; 134(5):402-3. PubMed ID: 10909562
    [No Abstract]   [Full Text] [Related]  

  • 17. Arrhythmic storm responsive to quinidine in a patient with Brugada syndrome and vasovagal syncope.
    Márquez MF; Rivera J; Hermosillo AG; Iturralde P; Colín L; Moragrega JL; Cárdenas M
    Pacing Clin Electrophysiol; 2005 Aug; 28(8):870-3. PubMed ID: 16105018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. To the editor: response---Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
    Estes NA; Page RL
    Heart Rhythm; 2010 Jun; 7(6):863-4. PubMed ID: 20226275
    [No Abstract]   [Full Text] [Related]  

  • 19. To the editor--Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine.
    Viskin S; Belhassen B; Wilde AA
    Heart Rhythm; 2010 Jun; 7(6):863. PubMed ID: 20226268
    [No Abstract]   [Full Text] [Related]  

  • 20. To the editor--Market withdrawal of quinidine bisulfate (Kinidin Durules) in 2006.
    Olsson G
    Heart Rhythm; 2010 Jun; 7(6):864. PubMed ID: 20226273
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.